about
Preferential short cut or alternative route: the transaxillary access for transcatheter aortic valve implantationMitraClip-data analysis of contemporary literatureThe MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signalingSOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.Transcatheter aortic valve implantation using the ACURATE TA™ system: 1-year outcomes and comparison of 500 patients from the SAVI registries.Predictors for quality of life of patients with a portable out-of-centre-implanted extracorporeal membrane oxygenation device.Transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement in patients with failed aortic bioprostheses.Direct aortic access for transcatheter aortic valve replacement with a fully repositionable and retrievable nonmetallic valve system.Data Science Meets the Clinician: Challenges and Future Directions.A matched pairs analysis of non-rib-spreading, fully endoscopic, mini-incision technique versus conventional mini-thoracotomy for mitral valve repair.Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions.Thirty-day VARC-2 and performance data of a new self-expanding transcatheter aortic heart valve.Myeloperoxidase acts as a profibrotic mediator of atrial fibrillationInitial experience of pacemaker and implantable cardioverter defibrillator lead extraction with the new GlideLight 80 Hz laser sheathsCoronary Sinus Lead Removal: A Comparison between Active and Passive Fixation Leads.Laser lead extraction allows for safe and effective removal of single- and dual-coil implantable cardioverter defibrillator leads: A single-centre experience over 12 years.Balloon expandable transcatheter aortic valve implantation via the transfemoral route with or without pre-dilation of the aortic valve - rationale and design of a multicentre registry (EASE-IT TF)Repeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves.Transcatheter Mitral Valve Repair in Surgical High-Risk Patients: Gender-Specific Acute and Long-Term Outcomes.The JUPITER registry: 1-year results of transapical aortic valve implantation using a second-generation transcatheter heart valve in patients with aortic stenosis.Cardiac surgery score (CASUS) improves outcome prediction in patients treated with extracorporal life support (ECLS).Carcinoid Heart Valve Disease: Transcatheter Pulmonary Valve-In-Valve Implantation in Failing Biological Xenografts.SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.JenaValve.Results of modern mitral valve repair in patients with Marfan syndrome.The best of both worlds: staged hybrid approach to complex cardiac disease in a patient at high surgical risk.One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation.Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study.An externalized transseptal guidewire technique to facilitate guidewire stabilization and stent-graft passage in the aortic arch.Improving outcomes: case-matched comparison of novel second-generation versus first-generation self-expandable transcatheter heart valves.Large Biatrial Thrombembolus Caught in Transit across a Patent Foramen Ovale.European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.Transcatheter valve-in-valve therapy using 6 different devices in 4 anatomic positions: Clinical outcomes and technical considerations.Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial.Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany.Trends in Surgical Aortic Valve Replacement in More Than 3,000 Consecutive Cases in the Era of Transcatheter Aortic Valve Implantations.Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis.Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
P50
Q26778719-B54BF26C-E9A9-471A-8AEB-8CCD6A875119Q26778739-6BAD1588-AE9D-4B5B-A92F-0A9D5BABE459Q28246833-1F6EA451-911D-411C-9A95-D32A8E857E7CQ30313107-8E52D907-3C52-43BB-92A9-EE3AF6C6C920Q30313449-8C54FE0A-54E8-4680-8841-D7B900E2E539Q30313574-E03D8363-52A2-446A-B362-6E1E72735809Q30313876-7090FE9E-BCA1-4CC3-B692-2FED61C009E2Q30313886-5DF22C1F-56AD-4581-A6A4-CDB0A987987DQ30313940-CB1113C0-9032-4906-8FA9-A8388C7D8894Q30314658-652B9C24-A3C1-4DF8-9104-360D4394C2A8Q30315877-9FA3CE66-19C3-4C79-8718-1687F04CA47DQ30953116-3E09A97A-78B0-4540-AE79-0795D5449193Q33894571-F2806819-43BD-4AFE-AE3C-5D2356B088CBQ35006607-DADF38A6-8152-48CF-9576-12818E0BAE58Q36000636-021C3454-C2E6-4186-9510-FFD940826AF6Q36131748-BEA4FF54-1AF9-4D7E-91F4-9AAAB7D6E00AQ36193252-C430CF46-D739-4FFB-AC73-6FE446DFF2D3Q36466843-344B3C9A-0DBB-4112-9D92-10C104CDE373Q36690586-184E69ED-0A60-40CA-98C9-A8E730F801E1Q38437765-19B31862-6EC3-4207-872A-4F08058B055AQ38633582-C3DFCFFE-8EA2-49B1-B8BA-4C5418278B68Q38984051-3AFF5931-5381-43CB-A62F-23E36222EF98Q39011251-AD221131-253E-4BD4-824C-C181B757545EQ39375165-863DA3AD-3203-4850-AF27-0EDCB5D7E731Q39387721-E8E1A28F-FE56-4D8D-962D-55D3D621119BQ39645854-AEFA9BB1-C6FA-4AF8-9E43-73CA276948DAQ39730028-B642FC6C-0AAF-465B-A2A9-21635D0DC498Q39797928-1D5EB249-54FF-44FF-AB41-F17EF753E751Q39832913-0B6ABE6E-1937-4D4F-B4EB-DAFC59DB5239Q39962146-8169FAAC-BBA2-4102-B805-4515B1FD03D6Q39989140-046314F3-01B0-466E-8675-1110C0326B9BQ40060627-D2EAAB93-5771-4156-9E18-3D86083E5362Q40278094-E6D281F4-5B57-45D2-9819-6EDBF90517CCQ40504890-743B9999-BC8F-4866-9AA2-2CA8C6B96DA6Q40706081-05369055-5D3F-4D26-AF0E-FFC39B086529Q40752504-D64A5751-3925-497D-9D90-ECD5083F8D8BQ41006124-8A3A96AD-7752-47B0-AB8E-EE877D81A63EQ41253392-32E5B84C-C73B-4840-AC90-9EDFD2DB28A8Q41335381-5B500EF9-A1D1-4500-9A4B-A2D1280A7781Q42274192-BF146331-9D7D-4C1C-A429-7FAB90403EAF
P50
description
onderzoeker
@nl
name
Hendrik Treede
@ast
Hendrik Treede
@en
Hendrik Treede
@es
Hendrik Treede
@nl
Hendrik Treede
@sl
type
label
Hendrik Treede
@ast
Hendrik Treede
@en
Hendrik Treede
@es
Hendrik Treede
@nl
Hendrik Treede
@sl
prefLabel
Hendrik Treede
@ast
Hendrik Treede
@en
Hendrik Treede
@es
Hendrik Treede
@nl
Hendrik Treede
@sl